News Earnings Kimia Biosciences Dispatches Postal Ballot Notice for Managing Director Re-appointmentKimia Biosciences Dispatches Postal Ballot Notice for Managing Director Re-appointment
Kimia Biosciences Limited has dispatched its postal ballot notice to shareholders on February 18, 2026, seeking approval for the re-appointment of Managing Director Sameer Goel for a five-year term from March 29, 2026 to March 28, 2031. The e-voting process will be conducted from February 20 to March 21, 2026, with Mr. Maghisuddin appointed as scrutinizer.
*this image is generated using AI for illustrative purposes only.
Kimia Biosciences Limited has dispatched its postal ballot notice to shareholders on February 18, 2026, seeking approval for the re-appointment of Managing Director Sameer Goel. The company had earlier approved the postal ballot process following board meetings held on February 14 and February 16, 2026, where it modified the original notice by withdrawing one agenda item.
Postal Ballot Process and Timeline
The postal ballot notice has been dispatched to all eligible shareholders whose email addresses are registered with the company or depositories as of the cut-off date of February 6, 2026. The company is conducting the postal ballot exclusively through electronic voting in compliance with MCA circulars and SEBI regulations.
| Parameter | Details |
|---|---|
| Notice Dispatch Date | February 18, 2026 |
| E-voting Commencement | February 20, 2026 at 9:00 AM (IST) |
| E-voting End Date | March 21, 2026 at 5:00 PM (IST) |
| Cut-off Date | February 6, 2026 |
| Scrutinizer | Mr. Maghisuddin, M/s M & Company |
Managing Director Re-appointment Details
The sole agenda item in the revised postal ballot seeks shareholder approval for the re-appointment of Mr. Sameer Goel (DIN: 00161786) as Managing Director for a five-year term. The board had earlier withdrawn the regularisation of Mr. Kaku Vijaya Shekhar Reddy as Whole Time Director from the postal ballot agenda.
| Appointment Details | Information |
|---|---|
| Candidate | Mr. Sameer Goel (DIN: 00161786) |
| Position | Managing Director |
| Term Duration | Five years (March 29, 2026 to March 28, 2031) |
| Previous Remuneration | ₹50 lakhs for FY 2024-25 |
| Shareholding | 35,455,776 equity shares of Re 1/- each |
Background and Qualifications
Mr. Sameer Goel, aged 52 years, is a Delhi University Commerce graduate with extensive experience in the Indian API market. As the founder of Kimia Biosciences Limited, he has established the company as a significant player in bulk drugs addressing various high-potential therapeutic segments. He possesses strong capabilities in business development, product development, strategic marketing, and operations management.
E-voting Process and Compliance
Shareholders can cast their votes through NSDL's e-voting platform at www.evoting.nsdl.com . The company has appointed Mr. Maghisuddin, proprietor of M/s M & Company, as the scrutinizer to oversee the e-voting process. The postal ballot notice is available on the company's website at www.kimiabiosciences.com and on BSE's website.
The resolution, if passed by the requisite majority, will be deemed to have been passed on March 21, 2026. The scrutinizer will submit the report within two working days of the conclusion of remote e-voting, and results will be declared and communicated to the stock exchange where the company's shares are listed.
Historical Stock Returns for Kimia Biosciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -7.47% | -7.93% | -20.23% | -24.93% | -38.68% | -29.72% |
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
